India court blocks Bayer generic drug appeal – Yahoo News
0
An Indian court has rejected German drug giant Bayer’s bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.
The judges rejected an appeal by Bayer on Friday that contested a March 2012 decision by India’s patent controller, who had argued the price charged by Bayer for the liver and kidney drug — $5,500-per-person, per month in India — was far too costly for most Indians.
Read more – Yahoo News